Literature DB >> 21119691

Liver regeneration from induced pluripotent stem cells.

Xin Cheng1, Paul Gadue.   

Abstract

Mesh：

Year:  2010        PMID： 21119691      PMCID： PMC2997596          DOI： 10.1038/mt.2010.237

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  11 in total

1.  Induced pluripotent stem cell-derived hepatocytes have the functional and proliferative capabilities needed for liver regeneration in mice.

Authors:  Silvia Espejel; Garrett R Roll; K John McLaughlin; Andrew Y Lee; Jenny Y Zhang; Diana J Laird; Keisuke Okita; Shinya Yamanaka; Holger Willenbring
Journal:  J Clin Invest       Date:  2010-08-25       Impact factor: 14.808

2.  Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells.

Authors:  Jose M Polo; Susanna Liu; Maria Eugenia Figueroa; Warakorn Kulalert; Sarah Eminli; Kah Yong Tan; Effie Apostolou; Matthias Stadtfeld; Yushan Li; Toshi Shioda; Sridaran Natesan; Amy J Wagers; Ari Melnick; Todd Evans; Konrad Hochedlinger
Journal:  Nat Biotechnol       Date:  2010-07-19       Impact factor: 54.908

3.  Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells.

Authors:  S Tamir Rashid; Sebastien Corbineau; Nick Hannan; Stefan J Marciniak; Elena Miranda; Graeme Alexander; Isabel Huang-Doran; Julian Griffin; Lars Ahrlund-Richter; Jeremy Skepper; Robert Semple; Anne Weber; David A Lomas; Ludovic Vallier
Journal:  J Clin Invest       Date:  2010-08-25       Impact factor: 14.808

4.  Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence.

Authors:  Qiang Feng; Shi-Jiang Lu; Irina Klimanskaya; Ignatius Gomes; Dohoon Kim; Young Chung; George R Honig; Kwang-Soo Kim; Robert Lanza
Journal:  Stem Cells       Date:  2010-04       Impact factor: 6.277

5.  Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I.

Authors:  M Grompe; S Lindstedt; M al-Dhalimy; N G Kennaway; J Papaconstantinou; C A Torres-Ramos; C N Ou; M Finegold
Journal:  Nat Genet       Date:  1995-08       Impact factor: 38.330

Review 6.  The promise of human induced pluripotent stem cells for research and therapy.

Authors:  Shin-ichi Nishikawa; Robert A Goldstein; Concepcion R Nierras
Journal:  Nat Rev Mol Cell Biol       Date:  2008-09       Impact factor: 94.444

7.  Generation of germline-competent induced pluripotent stem cells.

Authors:  Keisuke Okita; Tomoko Ichisaka; Shinya Yamanaka
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

8.  iPS cells produce viable mice through tetraploid complementation.

Authors:  Xiao-yang Zhao; Wei Li; Zhuo Lv; Lei Liu; Man Tong; Tang Hai; Jie Hao; Chang-long Guo; Qing-wen Ma; Liu Wang; Fanyi Zeng; Qi Zhou
Journal:  Nature       Date:  2009-09-03       Impact factor: 49.962

9.  Differentiation and transplantation of human embryonic stem cell-derived hepatocytes.

Authors:  Hesham Basma; Alejandro Soto-Gutiérrez; Govardhana Rao Yannam; Liping Liu; Ryotaro Ito; Toshiyuki Yamamoto; Ewa Ellis; Steven D Carson; Shintaro Sato; Yong Chen; David Muirhead; Nalu Navarro-Alvarez; Ronald J Wong; Jayanta Roy-Chowdhury; Jeffrey L Platt; David F Mercer; John D Miller; Stephen C Strom; Naoya Kobayashi; Ira J Fox
Journal:  Gastroenterology       Date:  2008-10-29       Impact factor: 22.682

10.  Epigenetic memory in induced pluripotent stem cells.

Authors:  K Kim; A Doi; B Wen; K Ng; R Zhao; P Cahan; J Kim; M J Aryee; H Ji; L I R Ehrlich; A Yabuuchi; A Takeuchi; K C Cunniff; H Hongguang; S McKinney-Freeman; O Naveiras; T J Yoon; R A Irizarry; N Jung; J Seita; J Hanna; P Murakami; R Jaenisch; R Weissleder; S H Orkin; I L Weissman; A P Feinberg; G Q Daley
Journal:  Nature       Date:  2010-09-16       Impact factor: 49.962
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.